Eli Lilly Aktie
785,00
EUR
+56,30
EUR
+7,73
%
807,89
USD
+43,20
USD
+5,65
%
vorbörslich
Eli Lilly Aktie Analyse
| 21.04.17 | Eli Lilly Underperform | BMO Capital Markets | |
| 15.10.12 | Eli Lilly underperform | Jefferies & Company Inc. | |
| 30.06.10 | Eli Lilly verkaufen | Soleil Securities Group, Inc. | |
| 14.12.09 | Eli Lilly sell | Goldman Sachs Group Inc. | |
| 01.12.09 | Eli Lilly sell | Goldman Sachs Group Inc. | |
| 20.08.09 | Eli Lilly underweight | Morgan Stanley | |
| 10.08.09 | Eli Lilly sell | Goldman Sachs Group Inc. | |
| 16.07.09 | Eli Lilly underweight | Morgan Stanley | |
|
Werbung
|
|||
| 07.04.09 | Eli Lilly underperform | Leerink Swann LLC | |
| 17.09.08 | Eli Lilly underweight | JP Morgan Chase & Co. | |
| 27.08.08 | Eli Lilly below average | Caris & Company, Inc. | |
| 26.10.07 | Eli Lilly underweight | Morgan Stanley | |
| 13.07.07 | Eli Lilly reduce | Jyske Bank | |
| 17.04.07 | Eli Lilly reduce | Jyske Bank | |
| 13.04.07 | Eli Lilly reduce | Jyske Bank | |
| 12.04.07 | Eli Lilly reduce | Jyske Bank | |
| 28.03.06 | Eli Lilly underperform | Evern Securities | |
| 28.03.06 | Eli Lilly Underperform | Friedman, Billings Ramsey & Co | |